The effects diabetes has on the neurovascular system during exercise by Brown, Ashlyn Victoria
  
 
 
 
 
 
 
 
Copyright 
by 
Ashlyn Victoria Brown 
2016 
 
 
The Report Committee for Ashlyn Victoria Brown 
Certifies that this is the approved version of the following report: 
 
 
The Effects Diabetes Has on the Neurovascular System during Exercise 
 
 
 
 
 
 
 
 
APPROVED BY 
SUPERVISING COMMITTEE: 
 
 
 
Audrey Stone 
Darla Castelli 
 
  
Supervisor: 
The Effects Diabetes Has on the Neurovascular System during Exercise 
 
 
by 
Ashlyn Victoria Brown, B.S.Ed. 
 
 
Report 
Presented to the Faculty of the Graduate School of  
The University of Texas at Austin 
in Partial Fulfillment  
of the Requirements 
for the Degree of  
 
Master of Science in Kinesiology 
 
 
The University of Texas at Austin 
May 2016 
  
 iv 
Abstract 
 
The Effects Diabetes Has on the Neurovascular System during Exercise 
 
 
Ashlyn Victoria Brown, M.S. Kin. 
The University of Texas at Austin, 2016 
 
Supervisor:  Audrey Stone  
 
The autonomic nervous system is responsible for the involuntary control of most 
visceral organs. This system greatly influences the neurovascular and cardiovascular 
systems while at rest and during exercise. Central command, the baroreflex, and the 
exercise pressor reflex are the three systems that are responsible for the distribution of 
blood during exercise. Specifically, the exercise pressor reflex plays a dominant role 
during exercise because it is influenced by metabolic and mechanical factors that affect 
the vasculature health. Diabetes mellitus is a metabolic disease that can alter the way 
these systems function within the body. The effects of neural damage and exercise-
induced hypoglycemia have been thought to be the sources behind the changes seen in 
the exercise pressor reflex. Currently, not a lot of research has been done on the exact 
mechanisms behind the changes of the exercise pressor reflex in diabetes; therefore, the 
explanations to these alterations are unknown. Thus, the purpose of this report is to 
develop a hypothesis for the effects of diabetes on the autonomic control of exercise, 
specifically the exercise pressor reflex. 
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Chapter 1:  Introduction 
The sympathetic and parasympathetic divisions of the autonomic nervous system 
are responsible for involuntary control of most visceral organs, including the heart and 
vascuature.
130
 At rest, these systems work together to maintain homeostasis within our 
bodies. Specifically, they are in control of aiding in the redistribution of blood flow so 
that the working muscles as well as the rest of the organs get an adequate supply of blood 
flow in order to function. During exercise, central command, the baroreflex, and the 
exercise pressor reflex use these systems to ensure that the neurovascular and 
cardiovascular systems sufficiently respond to metabolic and functional needs. However, 
various diseases, such as diabetes, can alter the way the neurovascular system responds. 
Diabetes, both I and II, are metabolic diseases characterized by insulin resistance. 
It is often accompanied by heart disease, blindness, kidney failure, and lower-extremity 
amputations.
6
 Additionally, neural damage, specifically diabetic neuropathy, has been 
said to be the cause of many of these complications.
136 
The same types of sensory nerves which are affected by diabetic neuropathy are 
also involved in the exercise pressor reflex. At this time, the effects of diabetes on the 
exercise pressor reflex are unknown. The purpose of this report is to provide background 
information on the autonomic control of exercise, specifically the exercise pressor reflex, 
as well as the effects of diabetes on sensory nerves in order to develop a strong 
hypothesis for the effects of diabetes on the exercise pressor reflex.  
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Chapter 2: Type I and Type II Diabetes 
Diabetes is a chronic disease in which the body cannot produce insulin or it 
cannot use the insulin it produces. Insulin is the hormone produced by the beta cells in 
the pancreas that controls the amount of glucose in the plasma. High blood sugar levels 
can lead to damaged organs, blood vessels and nerves. It is often a chronic, debilitating 
disease that can sometimes be fatal.
135 
TYPE I DIABETES 
Type I diabetes, also known as early-onset diabetes, juvenile diabetes, and 
insulin-dependent diabetes, is an autoimmune disease when the body does not produce 
enough insulin because the beta cells within the pancreas, the cells that produce insulin, 
are destroyed by the body’s immune system.135  An “environmental trigger,” for example, 
an unidentified virus, has been suspected to trigger this attack on the beta cells in some 
people that may be genetically predisposed; however, the mechanisms of development 
for Type I diabetes, as well as Type II, are unknown.
6
 In order for those with Type I 
diabetes to control their blood sugar, they use insulin injections which supplement for the 
insulin that is not being produced.  According to the American Diabetes Association, 
only 5% of people who have diabetes have Type I diabetes.
33
 It is usually diagnosed in 
young adults and children but can be diagnosed in anyone at any age.  
TYPE II DIABETES 
Type II diabetes is a major chronic disease where the body does produce insulin 
but the amount may not be enough or the cells within the body do not react to the insulin 
that is being produced. This lack of response to insulin is known as insulin resistance or 
insulin insensitivity.
135
 Initially, to compensate for this resistance, the pancreas may 
produce extra insulin; however, over time, it is unable to keep up with the production, 
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and the proper amount of insulin is not produced in order to keep the blood glucose levels 
regular.  It is more common in the overweight/obese population because it has been 
shown that the body releases chemicals that destabilize its cardiovascular and metabolic 
systems when one has a high percentage of visceral fat.
134
  Commonly, type II diabetes is 
associated with raised blood pressure, a disruption in blood lipid levels, and a propensity 
to develop thrombosis; also known as metabolic syndrome. Blood glucose lowering 
therapy tends to be required continuously due to the progressive high glucose levels that 
tend to worsen throughout the years.
134
  Type II diabetes is known to cause an increase in 
cardiovascular risk such as, coronary artery disease, peripheral artery disease, and carotid 
artery disease.  Additionally, persistent hyperglycemia can lead to permanent 
microvascular difficulties such as diabetic retinopathy, nephropathy and neuropathy 
which can result in amputation, painful symptoms, erectile dysfunction, and other 
issues.
134 
Type II diabetes is the most common form of diabetes; 95% of diabetes cases are 
classified as being Type II.  Currently, 18 million Americans are affected with Type II 
diabetes.  Demographically, there are groups that are at a higher risk for Type II diabetes 
than others.  African Americans, Latinos, Native Americans, and Asian Americans/ 
Pacific Islanders, in addition to the aged population, are more prone to having diabetes.
33
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Chapter 3: Autonomic Control of Circulation at Rest 
THE NEURAL CONTROL IN CIRCULATION 
The body’s organs and tissues are capable of receiving their functional and 
metabolic needs from peripheral circulation and its distribution of cardiac output. Blood 
flow within specific regions can be regulated locally or centrally. Locally, blood vessels 
have an intrinsic ability to respond to mechanical stimulation, such as shear stress and 
wall tension, as well as chemical stimuli, such as oxygen and metabolites. Central neural 
activity coincides with the local regulation by adjusting the cardiovascular function in 
order to meet the body’s needs.  The coordination of both systems is important in 
responding and creating accelerated changes in blood volume distribution, blood pressure 
changes, and the amount of changes and distribution in the cardiac output; all of which 
are essential in maintaining perfusion within the heart and brain.
130 
AUTONOMIC NERVES AND CARDIOVASCULAR CONTROL 
The autonomic nervous system consists of the sympathetic and parasympathetic 
branches. It controls all involuntary movements within the viscera including the heart and 
vasodilators. The motor control within the autonomic system consists of myelinated 
preganglionic fibers originating in the central nervous system (CNS). The axons of this 
system synapse on autonomic ganglia located outside of the central nervous system on 
the cell bodies of the unmyelinated postganglionic fibers. These fibers lead to an 
innervation on the effector organs. The preganglionic fibers within the parasympathetic 
and sympathetic systems of both CNS and peripheral nervous system are cholinergic, 
releasing the neurotransmitter acetylcholine which binds to nicotinic acetylcholine 
receptors on the postganglionic fibers evoking action potentials.
130
 The lengths of the pre- 
and postganglionic fibers differ between the sympathetic and parasympathetic systems. 
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The fibers within the parasympathetic division contain long preganglionic fibers that 
synapse on short postganglionic fibers emerging from ganglia near the effector targets. In 
contrast, the fibers within the sympathetic division are made up of short preganglionic 
fibers that synapse on long postganglionic fibers emerging from the paravertebral chain 
ganglia or collateral ganglia. Due to these differences, the discharge from each system 
can either cause a regional or localized response; sympathetic causing the more regional 
effect and parasympathetic causing the more localized effect.
130
  
Within the cardiovascular tissues, specifically cardiac and smooth muscle, the 
axons of the postganglionic neurons branch, coming into close contact with an abundant 
amount of effector cells. Within these neuronal branches are varicosities that contain 
synaptic vesicles full of neurotransmitters that are released with every action potential 
that travels along the axon. Thus, many effector cells can be innervated by a single 
neuron. Acetylcholine is the primary neurotransmitter released by the postganglionic 
parasympathetic neurons. This then binds to muscarinic acetylcholine receptors located 
on target tissues. Norepinephrine is the primary neurotransmitter released by the 
sympathetic postganglionic fibers, which binds to either the α- or β-adrenergic receptors. 
Norepinephrine can be repackaged in vesicles and released once more by successive 
action potentials, allowing it to have greater, prolonged effects than acetylcholine. The 
neural control of the cardiovascular system is primarily governed by the sympathetic 
nervous system because it largely contributes directly and indirectly to the control of the 
cardiac and vascular function; however, the parasympathetic nerves are also important in 
the effect of cardiovascular functions, despite their innervations being rather limited in 
comparison to the sympathetic division.
41 
As a whole, the neural control of the circulation is controlled by the 
parasympathetic innervation to the heart and the sympathetic innervation that can be 
 6 
classified into three main categories: barosensitive, thermosensitive, and glucosensitive. 
Arterial barorecepters control the barosensitive sympathetic efferent neurons. Ultimately, 
the baroreceptors control is determined by central control i.e. the limbic, cortical, and 
midbrain structures.
48 
AUTONOMIC NEURAL CONTROL OF THE HEART 
The autonomic nervous system has an immense impact on the heart because of its 
capability to control cardiac rate, conduction velocity, contraction, and relaxation. 
Parasympathetic and sympathetic fibers innervating the sinoatrial (SA) and 
atrioventricular (AV) nodes influence the cardiac rate and conduction velocity, whereas 
the contraction and relaxation effects of the heart are primarily facilitated by the 
innervation of the sympathetic fibers on the atrial and ventricular myocytes. Moreover, 
the parasympathetic nervous activity negatively regulates the heart rate.
69
 
Parasympathetic fibers influence the vagus nerve, releasing acetylcholine and activating 
the M2 muscarinic acetylcholine receptors which increase the potassium conductance of 
nodal cells.
69,130
 Because of the parasympathetic influence on the membrane polarization, 
the SA node decreases its firing rate which slows down the conduction in the AV node, 
resulting in an overall decrease in the intrinsic heart rate.   
The release of norepinephrine from the sympathetic fibers binds to the β-
adrenergic receptors. Activation of these receptors increases the heart rate by increasing 
the slope of diastolic depolarization in the SA node, which in turn increases the 
conduction within the AV node. Within the myocytes there is an increase in the 
membrane calcium currents and calcium release from the sarcoplasmic reticulum during 
each action potential, thus increasing force production. Additionally, calcium reuptake in 
the sarcoplasmic reticulum is improved, which allows for acceleration in the relaxation of 
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the heart.  Jointly, the effects sympathetic stimulation has on the contraction and 
relaxation of the heart allows for an increased stroke volume.
130 
It is important to note that in conscious humans, the major determinant of baseline 
heart rate is dependent upon the parasympathetic nerve activity within the heart, whereas 
the effects of the sympathetic nervous system are trivial.
53,130
 According to Smith, 
endurance exercise-trained humans demonstrated an amplified parasympathetic tone at 
rest when compared to sedentary individuals, allowing them to have a lower baseline 
heart rate,
124
 thus, confirming that the resting heart rate relies on a greater amount of 
vagal discharge and a moderate amount of tonic sympathetic discharge.
130 
SYMPATHETIC NEURAL CONTROL OF BLOOD VESSELS 
Most arteries, arterioles, and veins in the body are innervated by postganglionic 
sympathetic neurons; however, venules and capillaries do not have a direct innervation 
with the sympathetic neurons due to their lack of smooth muscle.
48,130
 The 
norepinephrine released by the sympathetic nerve terminals binds to the α1- or α2-
adrenergic receptors which are located on the vascular smooth muscle cells. This results 
in an increase of intracellular calcium. Vessels that have more than a single layer of 
smooth muscle communicate via gap junctions so that all the inner portions of the medial 
layer can contract; however, vessels that only contain a single layer of smooth muscle 
receive the sympathetic innervation on the outermost layer. 
In addition to the neurotransmitter norepinephrine, vascular sympathetic nerves 
may release cotransmitters. Neuropeptide Y (NPY) and ATP can both produce 
constriction by increasing intracellular calcium. NPY has the ability to also increase the 
constrictor effects of norepinephrine and ATP.  The contribution of NPY and ATP 
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towards sympathetic vasoconstriction is dependent upon the strength and pattern of 
sympathetic discharge and various vascular beds.
61 
Similar to the heart, a background level of vasoconstriction is set by sympathetic 
neuronal innervation.  This sympathetic tonic activity is called functional sympatholysis 
and can either cause more vasoconstriction with greater sympathetic outflow or lesser 
vasoconstriction with a withdrawal of sympathetic tone.  Functional sympatholysis 
allows for complete control of vascular tone by the sympathetic vasoconstrictor nerves, 
leaving no need for innervation by the parasympathetic vasodilator nerves.
130 
As stated earlier, the type of vessels involved that are innervated by the 
sympathetic system are important in the regulation of systemic blood flow. Arterioles in 
particular have a substantial role when it comes to total peripheral resistance. Blood flow 
has a direct variance with the fourth power of the vessel radius.  Resultantly, even the 
smallest of changes in the caliber of the vessel can have fairly large effects on vascular 
resistance and blood flow. Arterioles are the major resistance vessels and are composed 
of numerous layers of smooth muscle that largely help regulate regional blood flow. 
Therefore, the regulation of blood flow to individual organs and tissues is a powerful 
mechanism created by the sympathetic neural control of arteriolar resistance.
130 
Despite the various sympathetic neuronal innervations, all of the vessels do not 
respond equally. Dependent upon various factors such as local factors, the density of 
sympathetic innervation, the density and subtype of adrenergic receptors, the 
concentrations of vasoactive tissue metabolites, the differences in norepinephrine 
kinetics, and the vessel size and structure, the distribution of blood flow will differ. 
Responses, such as this, allow for the redistribution of cardiac output towards the parts of 
the vascular beds that are more essential while maintaining blood flow to the vital 
organs.
47,50,71 
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Veins tend to have a different response when compared to arteries and arterioles. 
Because they have a lesser amount of smooth muscle and therefore have a lesser amount 
of sympathetic innervation. This makes them more of capacitance vessels, and when 
stimulated sympathetically, or in other words constricted, they decrease tissue blood 
volume.
130 
CENTRAL INTEGRATION OF AUTONOMIC OUTFLOW 
The autonomic neurons regulating cardiovascular function are controlled by a 
system of neurons that are located in the medulla oblongata. This system can receive 
input from other structures within the brain such as the hypothalamus, cerebral cortex, 
and medullary chemoreceptors in addition to input from peripheral reflexes emerging 
from all of the afferent receptors located within the blood vessels, heart, lungs, skeletal 
muscles, skin, and viscera. The nucleus tractus solitarius (NTS) located in the medulla is 
where the descending signals from higher brain centers and the afferent sensory signals 
from the large systemic arteries, cardiopulmonary region, and some of the viscera 
synapse.  The spinal cord sends the other afferent inputs from the skin and skeletal 
muscles that detect various chemical and physical factors such as muscle stretch to tissue 
hypoxia and metabolites to the medullary vasomotor centers.
48
  
The primary site that regulates sympathetic outflow is the ventrolateral medulla 
(VLM), and this is where the neural pathways from the NTS project. The excitatory 
neurons within the rostral VLM synapse on the sympathetic preganglionic neurons within 
the intermediolateral (IML) gray column of the spinal cord. Inhibitory neurons in the 
caudal VLM project to the rostral VLM. Vagal outflow controlled by the medulla is also 
mediated by the NTS neurons that synapse on the preganglionic parasympathetic neurons 
in the dorsal motor nucleus of the vagus and the nucleus ambiguus.
130
 Rapid behavior-
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related adjustments to sympathetic tone are controlled by the limbic, cortical, and 
midbrain structures, but these structures are most likely not involved in the long-term 
regulation of blood pressure unless in the context of stress-related hypertension.
48 
ARTERIAL BAROREFLEX 
The arterial baroreflex is a negative feedback system that regulates the beat-to-
beat fluctuations that occur in arterial blood pressure.  There is a narrow range of blood 
pressure within animals that is best for maintaining adequate blood flow to the numerous 
vascular beds in the body. This set point is primarily determined by the central nervous 
system. A classic study done by Cowley et. al involved comparing the blood pressure 
recordings from a dog with an intact baroreceptor and a dog with a chronically 
denervated baroreceptor. When the arterial baroreceptor afferent nerves were officially 
severed, the arterial pressure rose substantially. However, after a period of time the mean 
arterial pressure returned to the levels of predenervation, thus making the levels of the 
normal dog and the denervated dog similar. Moreover, the baroreceptor-denervated dog 
had a greater variability around the mean arterial pressure because the beat-to-beat 
buffering system was no longer functioning.
23 
At rest, a lot of continuous information is being received from afferent 
baroreceptor projections. Simultaneously, the heart is receiving information from both 
branches of the autonomic system, and the balance between both systems determines the 
baseline heart rate. The sympathetic nervous system is also maintaining vascular tone. 
Therefore, under normal resting conditions arterial baroreceptors serve as a constraint, 
keeping the heart rate and arterial pressure lower than what they would be in the absence 
of baroreceptor input.
53
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In the heart, the acute changes in arterial blood pressure stimulated by the 
sympathoinhibitory reflex are due to stretch receptors, or baroreceptors, in the vessel wall 
of the carotid sinus and aortic arch. Typically, the discharge from the baroreceptors 
increases quickly during early systole and decreases during late systole and early diastole. 
The afferent baroreceptor discharge is relayed via the buffer nerves, to the NTS, which 
induces changes in the sympathetic and parasympathetic outflow to the heart and 
vasculature that are responsible for adjusting cardiac output and vascular resistance in 
order to return blood pressure back to baseline levels.
130
   Therefore, arterial baroreceptor 
discharge will decrease when arterial pressure is decreased; however, if arterial pressure 
increases, arterial baroreceptor discharge will increase inducing reflex inhibition of 
efferent sympathetic outflow to the blood vessels and heart and eventually causing an 
activation of parasympathetic outflow to the heart.
53,130
 Either an increase or decrease in 
arterial baroreceptor discharge results in changes in vascular resistance, stroke volume, 
and heart rate in order to get arterial pressure back to baseline.
130
 Stroke volume is largely 
influenced by venous return and cardiac contractility which both rely on the effects of the 
sympathetic nervous system; therefore, changes in the sympathetic nerve activity to the 
arteries and ventricles will affect stroke volume.
53 
If arterial pressure is changed for a period of time, it is possible for the arterial 
baroreceptors to reset and operate around a new baseline blood pressure. This process is 
capable of starting within minutes and eventually be completed within a few days to 
weeks.
73,74,76
 There is a sigmoidal relationship that exists between mean arterial pressure 
and afferent baroreceptor discharge.
130
 The exposure to an elevated arterial pressure will 
cause a rightward shift in the baroreceptor curve towards higher blood pressures, whereas 
a leftward shift in the baroreceptor curve towards lower blood pressures will occur in the 
presence of decreased blood pressures.
53
 This acute resetting of the baroreceptors and 
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baroreflex can be viewed as being advantageous because it allows for a wider range of 
pressures the baroreceptors can remain sensitive to that way they can immediately 
respond in pressure fluctuations.
53 
The arterial baroreflex resetting can either be acute or chronic. A good example of 
acute resetting is during exercise. The efferent baroreflex function curve shifts to the right 
and upward without a reduction in sensitivity. This allows for the blood pressure, efferent 
sympathetic nerve activity, and heart rate to stay at greater levels throughout exercise and 
decrease back to baseline once the exercise ceases.
130
 A chronic example of baroreflex 
resetting is the development of hypertension. Over time as the arterial pressure remains 
elevated, the sensitivity to the baroreflex can be reduced making it more difficult to 
buffer acute pressure fluctuations.
130 
ARTERIAL CHEMOREFLEX 
Arterial chemoreceptors are a collection of chemosensitive cells that are located 
in the carotid and aortic bodies within the aortic arch and respond to changes in arterial 
PO2, PCO2, and pH.
53,130
 They are primarily responsible for controlling respiration and 
serve to buffer changes in arterial blood gases. When arterial PO2 or pH decreases or 
arterial PCO2 increases, the afferent chemoreceptor nerves increase their discharge, which 
stimulates the respiratory center to reflexively increase ventilation, and volume as well as 
stimulates the vasomotor center to reflexively increase sympathetic outflow, which 
increases arterial blood pressure. Despite arterial chemoreflexes not being a major 
mechanism for blood pressure regulation, a lower than normal arterial pressure range 
activates arterial chemoreceptors.  This reflex causes the chemoreceptors to have an 
effect on arterial blood pressure.
53,130 
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Chapter 4: Autonomic Control of Circulation during Exercise 
During exercise, many mechanisms control the cardiovascular system in order to 
maintain adequate oxygen flow to the demanding muscles that are being exercised in 
order to provide sufficient nutrients and metabolites as well as washout the metabolic 
end-products. Such mechanisms provide a way to regulate arterial blood pressure so that 
the vital organs can maintain adequate perfusion without excessive pressure variations.
62
 
Systemic demands such as these provide a challenge to the cardiovascular system 
because active muscles during exercise induce metabolic vasodilation.
97
 Within skeletal 
muscle nearly a linear increase in blood flow is provided by vascular control 
mechanisms, which increases the oxygen consumption of the muscle due to changing 
oxygen extraction. The central control processes allow for a near-linear increase in 
cardiac output and heart rate that also are in line with the oxygen consumption of the 
muscle tissue. This increase in cardiac output is directly related to the vasodilation within 
the resistance vessels that is caused by the increased oxygen demand of the exercising 
skeletal and cardiac muscles.
144
  
Various exercises have different effects on the mean arterial pressure.  Dynamic 
exercise tends to slightly increase the mean arterial pressure whereas static and isomeric 
exercise progressively increases mean arterial pressure.  During physical activity that 
requires large muscle mass, the vasodilation that occurs in the active muscles results in a 
reduction in systemic vascular resistance; however, due to various control mechanisms, 
what would be a drop in blood pressure is augmented and cardiac output is maintained. 
Various vasodilators are released by active skeletal muscle such as potassium, adenosine 
hydrogen ions, carbon dioxide and phosphate. Nitric oxide is also produced thereby 
creating vasodilating effects. The cardiac output is increased by an increase in heart rate 
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and stroke volume, which act against the reduction in systemic vascular resistance via a 
flow-increment mechanism.
28,54,81,93 
Cardiovascular responses are controlled by mechanical mechanisms, such as the 
skeletal-muscle and respiratory pumps, which force blood towards the heart and by 
nervous mechanisms which help meet the metabolic demand from the exercising muscles 
by regulating vagal tone and flow.
97
 In regards to mechanical pumps, the skeletal-muscle 
pump has the most important role because the rhythmic pumping caused by muscle 
contractions during dynamic exercise creates intramuscular oscillations which facilitate 
blood flow to the heart and enhance cardiac preload. This then increases stroke volume 
because the Frank-Starling mechanism is recruited.
24,25,27,54,77,83,107
 In regards to 
regulation by the nervous mechanisms, exercise induces sympathetic activation and 
parasympathetic withdrawal, which are dependent upon the muscle mass recruited and 
exercise intensity.
119,121
 This autonomic regulation is determined by central command. 
This basic pattern of autonomic regulation is controlled by the mechanoreceptors and 
metaboreceptors within the muscle, which dictate sympathetic tone based off of the 
mechanical and metabolic conditions of the working muscle. This is called the exercise 
pressor reflex, which will be discussed more in depth later.
26,64,102,106,126
 Because of the 
exercise pressor reflex and sympathetic activation heart rate, myocardial contractility, and 
venous return increase which simultaneously raise cardiac output. As previously 
discussed, the arterial baroreflex determines sympathetic activation and can be reset 
during exercise.
97 
In summary, blood flow is controlled by the nervous system during exercise 
through neural integration within the brain and through the periphery. Within healthy 
individuals, the parasympathetic tone in the cardiovascular system, which tends to 
decline during exercise, is overshadowed by sympathetic activity.  The resulting 
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imbalance increases heart rate and myocardial activity while the vascular beds of the 
organs and tissues not involved in exercise undergo arterial constriction.  Moreover, 
cardiac preload is increased because of muscle pump activation and sympathetic-induced 
venoconstriction, which contribute to the increase in stroke volume that is common 
during dynamic exercise.
97 
CENTRAL COMMAND 
The term “central command” became a common use name used to describe the 
central neural mechanism due to the 1972 study done by Goodwin et al. at Oxford 
University. In this study, a vibration at the distal biceps tendon was applied during static 
contractions with the biceps or the triceps. The vibration was intended to activate muscle 
spindle afferents, which provided medullary excitation when the agonist muscle was 
stimulated, thereby reducing the central motor activation needed to reach a given tension. 
On the opposing hand, a vibration provided reflex medullary inhibition when it was 
applied to the antagonist muscle, causing a rise in central motor activation achieving a 
given tension.  What the researchers observed was that there was a decrease in heart rate, 
blood pressure, and pulmonary ventilation when central motor activation was reduced, 
and the opposite effect when central motor activation was increased.
45 
Further studies have been done after the Goodwin et al. study within animal 
models and humans using neuroimaging, deep brain electrical recordings, or deep brain 
stimulation and have validated and accepted that the central command is a feed forward 
process.
45
 This means that feedback information from skeletal muscles, blood, lungs, 
heart, etc. is not necessary in order to function. Conversely, other quantities of data have 
stated that the central and peripheral inputs can control the central command, yet this type 
 16 
of parallel motor activation is not necessary for the control of cardiovascular responses 
by central command.
97
   
A study done by Morgan et al.
95
 demonstrated this. Subjects had to exercise at a 
constant workload and were hypnotized being told that the load was light, moderate, or 
heavy. The cardiorespiratory responses and effort sense were higher during hypnotic 
suggestion but were not different between light and moderate hypnotic suggestions.
95
 A 
similar study was done by Williamson et al.
145 
using single-photon-emission measuring 
regional cerebral blood flow during exercise under hypnosis. Their findings supported the 
Morgan et. al findings since the sense of increased effort due to hypnosis during constant-
load exercise heightened cardiovascular responses, which is associated with the 
activation of the insular cortex, anterior cingulate cortex, and the thalamus. On the other 
hand, a reduction in effort sense that was induced by hypnosis did not decrease 
cardiovascular responses below the level needed to sustain the metabolic needs of 
exercise, despite there being a decrease in brain activation.
145
 The evidence from both 
studies suggests that the central command is autonomous in the presence of motor 
activation, and that the magnitude of cardiovascular response necessary for sustaining a 
given metabolic demand when effort sense is lower than a critical level is determined by 
the afferent input from the exercising muscle.
97 
Generally, numerous studies have found that central command does not operate 
well without adequate feedback from peripheral muscles. There are some limitations to 
this; however, the activation of central command leads to vagal withdrawal and 
sympathoexcitation.
98,104,146 
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BAROREFLEX 
There has been controversy on whether the strength or gain of the arterial 
baroreflex is reduced during exercise while both heart rate and arterial pressure rise. 
Some of the initial studies concluded that the arterial baroreflex does steadily decline 
while exercise workload increases
13,29
; however, following studies found sustainability in 
the reflex gain during exercise.
91
  Despite this dispute, the major mechanism used by the 
arterial baroreflex to control arterial pressure at rest and during exercise is the regulation 
of peripheral vasoconstriction.
19,105
 Temporary changes may occur in the cardiac output 
due to the initial carotid sinus perturbations, but these changes are not constant and in 
steady state, most of the reflex changes in pressure are because of the vascular 
responses.
105
 A larger fraction of cardiac output and total vascular conductance begins to 
incorporate the blood flow to the active skeletal muscle as workload increases. At greater 
workloads, the control of vascular conductance in the active skeletal muscle is the only 
way there can be effective regulation of arterial pressure.
103 
There is a resulting triphasic change during exercise in the vascular intraluminal 
pressure which is referred to as the myogenic response. Initially, there is a passive 
dilation in the arterioles that increase in pressure. As soon as the pressure is within the 
desired range, a myogenic constriction is elicited. Anything beyond the desired pressure 
range promotes an increase in dilation.
144
 There can also be a similar result in the 
relaxation of the vascular smooth muscle which is thought to be stimulated by 
acetylcholine.
34,146 
As stated earlier, the baroreflex is capable of resetting due to the stimulation of 
skeletal muscle afferents and the activation of the central command.
90,108
 Constant input 
to the central brainstem neural networks controlling baroreflex resetting is provided by 
the skeletal muscle afferents and central command activation as the workload increases. 
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The resetting occurs either through the ascending feedback input from the skeletal muscle 
mechanosensitive and metabosensitive group III and IV afferents or through the 
descending feed-forward input from central command.
97 
EXERCISE PRESSOR REFLEX 
The exercise pressor reflex can be termed as a “feedback” mechanism that 
originates in contracting skeletal muscle that functions to increase cardiovascular, 
ventilator, and locomotor function.
39,40,75
 It is likely that the cardiovascular and 
respiratory responses work together as part of the same reflex, and these together may be 
properly called the exercise reflex.
20
 The two reflexes termed the metaboreflex and the 
mechanoreflex are responsible for generating the exercise pressor reflex. The 
metaboreflex is defined as being the metabolic reflex devising from skeletal muscle that 
mediates the cardiovascular adjustments to exercise. The mechanoreflex can be defined 
as being the mechanical changes within muscles and tendons that create cardiovascular 
responses.
66,67
 Central command is also responsible for cardiovascular and ventilation 
increases; however, central command does not require muscle afferent input.
51 
There are four groups (I, II, III,and IV) of afferent fibers from skeletal muscle that 
are classically subdivided by their anatomically and electrophysiological characteristics.
85
 
It was McCloskey and Mitchell that showed the involvement of the group III and IV 
afferents in this reflex. They found that the cardiovascular and ventilator increases 
induced by static contraction were caused by the stimulation of group III and IV muscle 
afferents during the reflex.
87
  Efforts have been made for categorizing some of the group 
III and IV afferents into two groups.
65
  Nocioceptors are those of group III and IV 
afferents that a stimulated by algesic chemicals and vigorous pinching of the muscle, so 
they transduce muscle pain sensation.
70
 The fibers that cause the exercise pressor reflex 
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are called ergoreceptors and are thereby stimulated by skeletal muscular contraction.
65
 
The slow conducting afferent nerve fibers of groups III and IV have been thought to be 
excitable by mechanical and chemical stimulation.
68,79
 Specifically, group III thinly 
myelinated fibers probably serve as mechanoreceptors because they can be rapidly 
excited by mechanical distortion of their receptive field.
86
 The unmyelinated fiber group 
IV afferents are more often stimulated by mechanical stimuli. There is onset latency in 
which the metabolic products of contraction accumulate in the muscle undergoing 
constant contraction. The firing rate of these fibers increased throughout contraction 
because of the metabolite buildup.
1,52
 These mechanical conditions, such as muscle 
length and strain, tissue compression, and deformation due to contractions, and the 
metabolic conditions, such as the amount of metabolic accumulation, within the 
exercising muscles send information to the receptors within the muscles. In turn, the 
given information is provided for the cardiovascular controlling areas, which control the 
hemodynamic adjustments for the regulation of blood flow within the contracting 
muscle.
97 
There are different viewpoints that express the relationship between the 
metaboreflex and cardiovascular control. The first viewpoint is that the metaboreflex is 
activated whenever blood flow to the contracting muscles is unable to efficiently produce 
both oxygen delivery and metabolite washout.
21,106,115
 It is said that the metaboreflex acts 
as a way to correct any disconnect between muscle blood flow and metabolism by 
overlaying the activity of central command.
97
 The second viewpoint is that the 
metaboreflex is responsible for a tonically, active feedback to the cardiovascular control 
area that is activated once muscle contraction occurs.
2,3
 
 
The hemodynamic response to the metaboreflex is an increase in arterial blood 
pressure.
26,106,115
 The increase in systemic vascular resistance is thought to create this 
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cardiovascular adjustment because the periphery is undergoing sympathetic 
vasoconstriction.
106,115
 Heart rate is also affected by this reflex; in fact, it strongly 
depends on the setting of metabolic activation.
97
 Despite the fact that it is understood that 
the exercise pressor reflex is induced by contraction-induced metabolites, the exact nature 
of it is not known and is thought to be multifactorial. Specifically, bradykinins, 
cyclooxygenase products of arachidonic acid, lactic acid, purines, ATP, and adenosine all 
stimulate the exercise pressor reflex.
51 
The mechanoreflex has also been shown to produce a cardiovascular reflex. 
Within humans, the exercise pressor reflex can be evoked by the mechanical distortion of 
receptive fields of sensory nerve endings in the contracting muscle.
42,59
 It appears that the 
main effect of mechanoreflex activation is inhibiting cardiac vagal tone which produces a 
rapid and sustained increase in heart rate at the onset of exercise.
67,100
 This is either done 
by directly creating mechanical stimuli or by modifying the mechanical response by a 
chemical mediator.
20
 However, mechanoreflex has been hard to distinguish from 
metaboreflex activation. Evidence suggests that mechanoreceptors are sensitive to 
metabolite accumulation, thus enhancing the sympathetic response that arises from their 
activation; therefore, this makes it difficult to distinguish true mechanostimulation from 
metabostimulation.
96
 The damage of one or more of the cardiovascular parameters 
controlled during the metaboreflex can lead to an altered hemodynamic response, which 
can be seen in various cardiovascular and metabolic diseases such as hypertension, 
metabolic syndrome, obesity, and type I and 2 diabetes mellitis.
97 
Combined Effects of Exercise Pressor Reflex 
An animal study done on rats by Stone et al. measured the effects of combined 
receptor blockade that is required to attenuate the exercise pressor reflex. Initially, the 
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researchers of this study individually blocked purinergic 2X (P2X) receptors, acid-
sensing ion channel 3 (ASIC3) channels, and EP4 receptors.
125
 Lactic acid, prostaglandin 
E2 (PGE2), and adenosine triphosphate (ATP) are all substances produced during 
muscular contraction.
4,88,114,127
 The muscle interstitium, where many nerve endings of the 
Group III and IV afferents are located, is where all of these substances accumulate during 
exercise.
125
 The role these substances play in the exercise pressor reflex is controversial. 
The researchers found that individually blocking each receptor had minimal effects on the 
exercise pressor reflex. Instead, it was the blockade of all three receptors that attenuated 
the exercise pressor response. They found that the peak pressor response was reduced by 
27% and the overall pressor component of the reflex was reduced by almost half. The 
blockage of one receptor did not have an effect on the exercise pressor reflex because the 
remaining input from the other receptors helped compensate and stimulate the reflex at its 
preblockade magnitude. Contrarily, removing all three receptors caused a reduction in the 
afferent input to the dorsal horn of the spinal cord that made the reflex insufficient in 
maintaining the preblockade magnitude.
125 
The cardioaccelerator response to contraction was not affected despite the 
response of a reduction in blood pressure. The authors of the study interpreted this 
finding as the receptors not having an effect on the metaboreflex control in rats. On the 
other hand, the decrease in baroreceptor stimulation observed before combined blockade 
caused by an attenuated pressor response could be a possible explanation to the 
researchers’ findings of the combined blockade not decreasing the cardioaccelerator 
response to contraction. As a result, the reduced baroreflex opposed the effect on heart 
rate of a reduced exercise pressor reflex, thus resulting in an identical cardioaccelerator 
response to contraction before and after combined blockade.
125
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In summary, the metabolite receptors of the group III and IV afferents work 
together in order to maintain the exercise pressor reflex. If there is a blockage, the 
receptors can compensate for that reduction in order to maintain the reflex. Additionally, 
there is still the stimulation of mechanoreceptors that can be found in the exercise pressor 
reflex. 
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Chapter 5: The Effect of Type I and II Diabetes on the Autonomic 
Control of Circulation 
As stated in the previous chapter, the exercise pressor reflex causes an increase in 
sympathetic activity which in turn increases cardiac output and peripheral 
vasoconstriction. However, the mechanisms involved in the metaboreflex response are 
constantly dependent on whether there is a rise in cardiac output, and this can be seen in 
those with diabetes.
63 
Diabetic patients are prone to cardiovascular diseases such as hypertension, 
atherosclerosis, congestive heart failure, and cardiac autonomic neuropathy.
134
 High 
morbidity and mortality rates are associated with patients with autonomic neuropathy 
because it is one of the most common complications of diabetes mellitus.
136,147
 Many 
believe that the increased mortality rate may be related to the disorders within 
cardiovascular control, which include impairments in autonomic reflex control.
32 
It has frequently been described that individuals who have Type I diabetes have a 
reduction in catecholamine levels during exercise. A sympathetic deficit is created 
because adrenaline tends to not respond to hypoglycemia in these individuals.
113
 An 
almost complete loss of response of glucagon is seen within these individuals. Normally, 
adrenaline is the response for hormonal counterregulation when an individual is glucagon 
deficient; however, the adrenaline responses are blunted.
11
 Several studies support the 
idea of there being an association with autonomic neuropathy and hypoglycemia in Type 
I diabetes; however, there are others that disagree. 
DIABETIC NEUROPATHY 
Diabetic neuropathy incorporates dissimilar disorders that involve proximal, 
distal, somatic, and autonomic nerves. It is capable of being an acute, self-limiting 
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condition or a chronic, indolent condition because it can affect distinct regions of the 
nervous system.
136
 The causative factors include persistent hyperglycemia, microvascular 
insufficiency, oxidative and nitrosative stress, defective neurotrophism, and autoimmune 
mediated nerve destruction.
136
 Diabetic neuropathy is the most common and taxing 
complication when it comes to diabetes mellitus. The neurological complications 
associated with diabetic neuropathy equally occur in type I and type II diabetes mellitus 
as well as in other forms of acquired diabetes.
35
 For example, due to the precursor of 
gangrene and limb loss, foot ulceration is a major morbidity associated with somatic 
neuropathy. Neuropathy accounts for more hospitalizations than all other shared diabetic 
complications and is responsible for 50-75% of non-traumatic amputations.
14,60
 The 
quality of life for a patient with diabetic neuropathy is tremendously impacted because 
weakness, ataxia and incoordination predisposing to falls and fractures are caused.
140
 Life 
for these individuals can become quite bleak and the mortality rate approximates 25-50% 
within 5-10 years once autonomic neuropathy sets in.
80,110 
Different types of diabetic neuropathy can often coincide in the same patient.
136
 
Different types of neuropathies progress differently, and this is a way to separate them 
into separate entities. Sensory and autonomic neuropathies generally progress 
gradually.
143
 The progression is related to the glycemic control of both types of diabetes 
mellitus.
30,31
 Patients presenting with painful neuropathy typically have impaired fasting 
glucose or impaired glucose tolerance and are typically overweight and have autonomic 
dysfunction 50% of the time.
122
 Soon after the onset of type I diabetes is when the most 
rapid deterioration of nerve function occurs; then within 2-3 years, the progress slows and 
the slope to the curve of dysfunction shallows. Conversely, type II diabetes shows a 
slowing of nerve conduction velocities as being one of the earliest neuropathic 
abnormalities that is often present after diagnosis.
148
 There is a positive correlation to the 
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duration of diabetes and the level of impairment because after diagnosis, the slowing of 
nerve conduction velocities generally progresses at a steady rate of approximately 
1m/sec/year.
136 
Pain in Diabetic Neuropathy 
Pain is a common reason for patient visits in a primary care setting. About 2.7 
million patients have painful neuropathy in the US.
136
 Chronic pain may be nocioceptive 
or neuropathic. Nocioceptive pain “occurs as a result of disease or damage to tissue 
wherein there is no abnormality in the nervous system or there may be no somatic 
abnormality.”133 Contrarily, neuropathic pain is defined as “pain arising as a direct 
consequence of a lesion or disease affecting the somatosensory system.”133 It can come 
from neuronal dysfunctions along the most peripheral part of the somatosensory system, 
such as the nocioreceptor terminal membrane, to the cortical neurons within the 
somatosensory system. Peripheral sensitization may be induced by nerve damage. The 
release of inflammatory mediators activates intracellular signal transduction pathways in 
the nocioreceptor terminal and is related to the peripheral sensitization. The activated 
intracellular signal transduction pathways prompt an increase in the voltage-gated ion 
channels and the production, transport, and membrane insertion of transducer 
channels.
5,22
 Following nerve damage, various voltage-gated sodium channels are up-
regulated at the site of lesion and the dorsal root ganglion membrane. This promotes 
ectopic spontaneous activity along the primary afferent neuron and determines 
hyperexcitability that is related to a decreased activation threshold, hyper-reactivity to 
stimuli, and irregular release of neurotransmitters.
5
 Consequently, because of this 
hyperactivity in the primary afferent nocioceptive neurons, neuron hyperexcitability 
higher up in the central nervous system and dorsal horn of the spinal cord may occur as 
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secondary changes.
136
 This is known as central sensitization and is a form of use-
dependent synaptic plasticity which is considered a major pathophysiological mechanism 
of neuropathic pain.
22 
It is becoming clearer that the contributing factors causing pain have strong 
neuro-endocrine, autonomic, pro-inflammatory, and neuro-degenerative 
influences.
10,94,109,118
 Increasing evidence has supported the role of inflammatory 
cytokines such as IL6, TNFa, chemokines, adhesion molecules and acute phase reactants, 
and activation of the oxidative/nitrosative stress pathway invoking NFkb, all playing an 
important role in the complex relationship among the macrophages, adipose tissue, and 
glial and dendritic cells in the nervous system.
118
 A study done by Martinez-Lavin 
demonstrated that the infusion of norepinephrine heightens the pain experienced.
84
 Also, 
with the increases in the circulation of IL-6, IL-8, and IL 1-ra, there is a significant effect 
of chronic pain on immune function.
142
 IL-8 is a proinflammatory cytokine responsible 
for mediating sympathetic pain; IL 1-ra contributes to stress; and IL-6 is involved with 
stress, fatigue, hyperalgesia, and depression and activates sympathetic pain.
142
  
Out of all the complications associated with diabetes, diabetic periphery 
neuropathy is the most common because it is seen in both type I and type II diabetes with 
similar frequency. According to the Toronto Diabetic Neuropathy Expert Group, diabetic 
peripheral neuropathy is defined as being a symmetrical, length dependent sensorimotor 
polyneuropathy attributable to metabolic and microvascular alterations as a result of 
chronic hyperglycemia exposure, such as diabetes, and cardiovascular risk covarities.
129
 
It can be subdivided into focal/multifocal neuropathies, such as diabetic amyotrophy, and 
symmetric polyneuropathies, including sensorimotor polyneuropathy, which is 
considered the most common.
136
 Loss of thermal and pain perception is a result due to the 
loss of small fiber-mediated sensation, whereas the loss of touch and vibration perception 
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results from the large fiber impairment. “Positive” symptoms, such as paresthesias and 
pain, may also occur due to sensory fiber involvement. Patients may also experience 
negative symptoms such as numbness in the feet and legs which in time can lead to 
painless foot ulcers and subsequent amputations if the neuropathy goes unnoticed and 
treated.  Unsteadiness may also be seen frequently due to abnormal proprioception and 
muscle sensory function.
136
  
Diabetic peripheral neuropathy is frequently paired with the autonomic nervous 
system and classified as diabetic autonomic neuropathy. It rarely causes severe 
symptoms, but in its cardiovascular form the risk for mortality can increase at least a 
three-fold.
12,137-139,149 
Autonomic Neuropathy 
Blood glucose levels are normally maintained during starvation or increased 
insulin action by an asymptomatic parasympathetic response with mild hypotension and 
bradycardia, followed by a sympathetic response with epinephrine and glucagon 
secretion for short-term glucose counterregulation, and growth hormone and cortisol 
secretion for long-term regulation.
92
 The catecholamine release acts as an alert for 
patients to take the necessary measures to prevent coma due to low blood glucose. When 
a patient doesn’t have these warning signs of imminent neuroglycopenia it is called 
“hypoglycemic unawareness” and is a symptom of autonomic neuropathy.92 The absence 
of glucagon and epinephrine responses to hypoglycemia induced by a normal, consistent 
dose of insulin confirms the failure of glucose counterregulation.
92
 Studies have shown 
that due to the reduction in catecholamines, the maximal tolerable workloads and 
maximal oxygen consumption are reduced.
111
 Those with type I diabetes mellitus and 
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autonomic neuropathy have an absence of the glucagon and adrenaline response, and this 
defect is considered to be irreversible.
11,136 
Studies That Do Support Hypoglycemia and Autonomic Neuropathy  
Hypoglycemia primarily develops because of therapeutic insulinemia and may 
develop into a more severe episode because of the impaired responses of the 
counterregulatory hormones.
11
 As stated above, the response during exercise of 
catecholamines to hypoglycemia is blunted in patients with type I diabetes mellitus; thus, 
suggesting that there is a loss of sympathetic response to various stimuli. An elevated 
sympathetic drive is vital to the metaboreflex; therefore, impairment to the sympathetic 
system can affect the hemodynamic responses to metaboreflex recruitment.
113 
A study done by Roberto suggested that patients with Type I diabetes without 
autonomic neuropathy were unable to elevate sympathetic tone which blunts the mean 
blood pressure response to the metaboreflex. Compared to the controls, the 
catecholamine levels were reported to be lower in the diabetic subjects; type I diabetic 
patients exhibited a reduced capacity to increase systemic vascular resistance in response 
to the metaboreflex; stroke volume was higher during the metaboreflex in the type I 
diabetic patients than in the controls.
113
 All of this indicated that the cardiovascular 
regulation was altered in the patients with type I diabetes. A speculation that has been 
made for this phenomenon is that autonomic failure may be an outcome because of 
continuous incidents of overt or subclinical hypoglycemia that may reduce the capability 
to initiate sympathetic tone.
43,89,113
 Despite these results being found in patients without 
autonomic neuropathy, similar results have been found in patients with the disorder. 
For short durations, adrenaline responses tend to be normal or reduced in type I 
diabetics, but in the long-term, they tend to become blunted. Autonomic neuropathy, 
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hypoglycemia-associated autonomic failure, and diabetes are all proposed possible 
causes.
11
 Bottini et. al conducted a study measuring the effects diabetic autonomic 
neuropathy and hypoglycemia in patients with postural hypotension and diabetic 
neuropathy and in patients without postural hypotension and with diabetic neuropathy. 
The results found that in type I diabetic patients without clinically overt autonomic 
neuropathy, the responses of adrenaline to hypoglycemia were blunted in comparison to 
the nondiabetic subjects.
11
 Contrarily, in the presence of autonomic neuropathy, the 
responses of adrenaline to hypoglycemia in patients with type I diabetes were even 
further reduced.
11
 These results indicate that autonomic neuropathy further impairs the 
adrenaline response to hypoglycemia. A study done by Dagogo-Jack found similar 
results.  
Both studies demonstrated that autonomic neuropathy in its stage of predominant 
parasympathetic involvement concerning the cardiovascular reflexes is associated with 
marked deficiency of adrenaline responses to hypoglycemia. In the Bottini study, this was 
found in the patients that had diabetic autonomic neuropathy but lacked postural 
hypotension. This deficiency appears to be as severe as that in patients with more severe 
autonomic neuropathy i.e. patients with diabetic autonomic neuropathy and postural 
hypotension in the Bottini study.
11
 Lastly, the Bottini study indicates that patients with 
type I diabetes and without diabetic autonomic neuropathy have a deficient adrenaline 
response to hypoglycemia, but rather than being absolutely selective it is relatively 
selective because it is largely preserved in response to a stimulus that is different from 
hypoglycemia.
11 
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Studies That Do Not Support Hypoglycemia and Autonomic Neuropathy 
On the contrary, there are studies that disagree with the explanation of diabetic 
autonomic neuropathy being the suggested etiology for the cause of defective adrenaline 
secretion in insulin-dependent diabetics. RE Ryder is one of these researchers who felt 
that the studies that attributed diabetic autonomic neuropathy to the cause of defective 
adrenaline secretion used limited assessments of autonomic function; therefore, the 
present study used more extensive investigations to reexamine the relations between 
autonomic neuropathy, hypoglycemic unawareness, and inadequate hypoglycemic 
counterregulation.
117 
There were five groups of patients: the controls, patients with adequate 
counterregulation, patients with inadequate counterregulation, patients with adequate 
counterregulation but without autonomic neuropathy, and patients with autonomic 
neuropathy. Out of the seven patients that had autonomic neuropathy, only one had 
marginal results that were for inadequate hypoglycemic counterregulation and the rest 
had sufficient counterregulation. Out of the seven patients that had inadequate 
counterregulation, there was little evidence of autonomic neuropathy. There is evidence 
suggesting that diabetic autonomic neuropathy is symmetrical polyneuropathy that affects 
the longest fibers first, similar to diabetic peripheral neuropathy of the sensory type.
131,132
 
Consequently, sweating abnormalities in the feet may be present in advance of 
abnormalities that were evident in the cardiovascular autonomic function tests which is 
one of the tests performed in the study.
117
 Moreover, if diabetic autonomic neuropathy 
affects the longest fibers first and is present anywhere in the body, then it should also be 
present on the feet. In this study, only one out of seven patients with inadequate 
hypoglycemic counterregulation had an abnormal sweatspot test result, making 
autonomic neuropathy as cause for the defect unlikely. 
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 It is true that patients with autonomic denervation have reduced adrenaline 
responses to hypoglycemia, but they also have increased sensitivity to catecholamines.
57
 
Ryder accounts the sensitivity to catecholamines to the patients of their study with 
autonomic neuropathy not having inadequate hypoglycemic counterregulation or 
unawareness of hypoglecemia.
117
 According to the authors, the attribution of the 
unawareness of hypoglycemia to diabetic autonomic neuropathy is erroneous. The results 
of this study therefore suggest that there is no relation between autonomic neuropathy 
and either unawareness of hypoglycemia or the hypoglycemic counterregulatory defect 
and these problems have an entirely different etiology. Instead, the etiology thought to be 
the reason behind this phenomenon is that the autonomic activity during hypoglycemia is 
abnormally diminished rather than the cause being autonomic neuropathy, meaning that 
the nerves are present but are not being activated.
117
  
Another study done by Hoffman assessed whether the pathogenesis of the 
decreased response of catecholamines in children and adolescents with type I diabetes is 
due to the relationship to autonomic neuropathy or hyperinsulinism. The authors found 
that after insulin withdrawal, there is a diminished catecholamine response to 
hypoglycemia compared to the control subjects and that short-term intensive insulin 
therapy reduces the response further.
58
 Therefore, the suppression of the catecholamine 
response is due to hyperinsulinism, and there was no evidence for the role of autonomic 
neuropathy as an explanation for this suppression.
58 
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Chapter 6: Conclusion 
In conclusion, the effect of diabetes mellitus on the exercise pressor reflex is 
unknown. The majority of the studies that have been done on this topic are on diabetic 
individuals that are insulin-dependent, and is likely because hypoglycemia is a common 
clinical problem found in insulin-dependent diabetics whereas type II diabetics more 
commonly experience hyperglycemia.
111
 It is possible for a type II diabetic to be 
hyperglycemic, but it is not common.
111
 Therefore, I will only focus on individuals with 
type I diabetes. 
Based on the reported studies, I believe that a patient with type I diabetes will still 
have an exercise pressor reflex; however, the reflex will be weaker and unable to be 
sustained for a long period of time or at a high workload due to autonomic neuropathy. 
Not many studies have been done on patients with type II diabetes; however, I believe 
that they will experience greater sympathetic tone in the exercise pressor reflex compared 
to the type I diabetics but will have lesser sympathetic tone than a healthy individual.
113
 
My deduction can be supported by the following studies. 
IMPAIRMENT IN HEART RATE AND BLOOD PRESSURE 
The first study found impairment in the increase of heart rate and a lower blood 
pressure and aerobic capacity in patients with diabetic neuropathy. Circulatory and 
metabolic adjustments during exercise are generally considered important in the changes 
within the autonomic nervous system.
116
 Hilsted and colleagues did a study determining 
whether the decreased beat-to-beat variation in heart rate during deep respiration implies 
that the blood pressure and heart rate responses to exercise capacity are impaired in 
diabetics.
55
 The study revealed dysfunction of the sympathetic and parasympathetic 
regulation during graded exercise in diabetic autonomic neuropathy. Six similarly aged, 
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type I diabetics with the mean duration of diabetes for 15 years participated in the study. 
They had signs of autonomic neuropathy meaning that they had a decreased beat-to-beat 
variation in heart rate during deep breathing. Seven control patients of similar age and 
duration of diabetes also participated in the study. The participants had to perform graded 
exercise on an ergometer cycle until exhaustion.  
The resting heart rate was higher and the increase in heart rate at the lowest 
workload was lessened in the patients with autonomic neuropathy compared to the 
control group, thus indicating a vagal defect.
55,82
 For a given type of exercise in healthy 
people, the oxygen uptake in percent of the maximal oxygen uptake has a closer 
relationship to the increased sympathetic outflow to the heart and to peripheral resistance 
vessels than does the actual work load.
18
  This is because the body size and degree of 
training dictate the amount of stress caused by a certain work load.
55
 With that said, in 
this study, the patients with decreased beat-to-beat variation needed to be more stressed 
in order to reach a given heart rate when compared to the controls. An interesting finding 
in this study is that when the autonomic neuropathy diabetic subjects were given atropine, 
a parasympatholytic drug, and propranolol, a beta blocker, the relationship between heart 
rate and relative work load corresponded exactly to that seen in the normal subjects.
38,55 
A REDUCTION IN MAXIMAL OXYGEN UPTAKE 
Many studies had similar findings that the VO2 max was reduced in subjects with 
diabetic neuropathy when compared to the subjects with diabetes but without 
neuropathy
55,72
 that the exercise-induced increases in catecholamines, cortisol, and 
growth hormones are depressed.
56
 In the Kremser article, the oxygen uptake kinetics was 
measured during exercise in patients with diabetic neuropathy. Seven diabetic patients 
with peripheral sensory and cardiac autonomic neuropathy were measured against eight 
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diabetics without neuropathy, and eight normal subjects. The maximal oxygen uptake, 
ventilatory anaerobic threshold, and oxygen uptake kinetics were assessed. In the patients 
with diabetic neuropathy, the VO2 max was reduced compared to the diabetic and normal 
participants.
72
 However, the ventilatory anaerobic threshold showed no difference 
between the groups. Importantly, during the constant-load exercise at 40% VO2 max, the 
estimated cardiac output and the time constant were similar in all groups. Kremser and 
colleagues believe that the instantaneous increase in the maximal oxygen uptake  and 
cardiac output at exercise onset in diabetes with weakened neurogenic reflexes is 
primarily caused by metabolic and mechanical events in the exercising muscle that cause 
venous compression and vasodilation.
72 
One of the possibilities attributed to the reduction in VO2 max by Kremser and 
colleagues was insulin deficiency. The depletion of muscle glycogen stores can deprive 
the muscle of the substrate needed for performance of heavy exercise. However, the 
researchers found similar levels of glycosylated hemoglobin during the time of exercise, 
which indicated similar degrees of glucose homeostasis for months prior to the study.
72
 
Additionally, the researchers normalized the blood glucose levels twelve hours before 
and during exercise; so, insulin deficiency is not an explanation for a reduction in VO2 
max in neuropathic diabetics according to Kremser and colleagues.
72 
The sympathetic nervous system during maximal exercise stimulates the heart and 
peripheral circulation in order to increase heart rate and contractile force, to maintain 
perfusion pressure throughout the body while redirecting cardiac output toward the 
exercising muscle, and to maintain a pressure gradient for venous blood pressure as it 
returns to the heart.
123
 In support of Hilsted article, Eckberg et al. demonstrated that 
patients with peripheral and parasympathetic nervous system abnormalities also exhibit a 
dysfunctional sympathetic nervous system.
36
 The participants of the study exhibited 
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reduced basal plasma norepinephrine concentrations, blunted heart rate and 
norepinephrine concentration changes in response to baroreceptor stimulation, and a 
greater than normal increase in blood pressure in response to phenylephrine infusion, 
which indicated denervation hypersensitivity.
36
 In the Kremser study, the absence of 
parasympathetic control of the heart rate and extensive peripheral sensory neuropathy 
among neuropathic diabetics is believed to suggest defects in sympathetic nervous 
control, which may play an important role in VO2 max reduction seen in these patients.
72 
The blood lactate threshold in the diabetic subjects with neuropathy was normal 
despite a reduced exercise cardiac output; however, the mechanism that maintains a 
normal blood lactate is unknown.
72
 Additionally, contraction is achieved from high-
energy phosphates and muscle stores of oxygen and from the conversion of muscle 
glycogen stores to lactate during the first few minutes of exercise before VO2 reaches a 
new steady state.
78
 Because a normal time constant for VO2 is preserved, this may 
suggest that muscle glycogen stores during the transition from rest to exercise are not 
unduly exerted by diabetic neuropathy. This is important especially during periods of 
insulin deficiency when there is a depletion of glycogen stores due to a lack of 
extracellular substrate for glycolysis.
72 
The diabetics with neuropathy in this study exhibited a preservation of a normal 
phase I VO2 which was similar to normal subjects.  This means that during the first 15s 
of exercise, before venous blood from the legs has reached pulmonary circulation, the 
arteriovenous difference was essentially unchanged.
37
 The increase of VO2 occurring 
during this period is a result of an increase in cardiac output as well as stroke volume.
72
 
Because the phase I VO2 was unchanged, this suggests that a substantial portion of the 
immediate increase in blood flow at the beginning of exercise is comprised of 
nonneurogenic influences.
72
 An animal study done by Guyton et al. demonstrated that 
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cardiac output increased even when the sympathetic nervous response was blocked by 
hexamethonium.
49
 This increase seen in cardiac output was a result of mechanical 
compression of skeletal muscle veins.
72
 It is likely that the local metabolic factors that 
induce vasodilation played a role by facilitating cardiac emptying.
123 
HYPOGLYCEMIA AND A REDUCTION IN CATECHOLAMINES AND HORMONES 
The plasma concentrations of norepinephrine and epinephrine are exaggerated in 
exercise-induced increments in poorly controlled insulin-dependent diabetics; as a 
consequence, there are increases in heart rate and plasma concentrations of free fatty 
acids and glucose.
16,128
 Contrastingly, better-controlled diabetics may develop 
hypoglycemia during or after exercise. This observation can be explained by serum 
insulin not being suppressed during exercise. Thus, an adequate increase of hepatic 
glucose production may not occur.
111,141 
Diabetic patients with autonomic neuropathy tend to have a severely impaired 
exercise performance. The adrenergic activity is deficient, so the maximal tolerable work 
load, the maximal heart rate, and the maximal oxygen uptake as well as the plasma 
catecholamine concentrations during maximal work load are lower than diabetic patients 
without neuropathy.
56,57
 According to Christensen and Galbo, the plasma concentration of 
norepinephrine has a close relationship to pulmonary arterial oxygen saturation and 
increases in proportion to the workload.
15
 This is in concordance with the Kremser and 
Eckberg studies presented earlier.  
In a healthy individual, plasma epinephrine is dependent on the general level of 
sympathetic nervous activity,
17
 which is reflected by plasma norepinephrine, as well as 
on the plasma glucose concentration.
111
 When plasma glucose begins decrease, plasma 
epinephrine tends to increase; however, it is only once norepinephrine has increased that 
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epinephrine then increases.
44
 The increase in plasma epinephrine is most likely a 
response to maintain normoglycemia during prolonged exercise. As a result, lipolysis is 
enhanced, there is a stimulation of hepatic glycogen breakdown, and muscular glycogen 
breakdown is enhanced during prolonged exercise.
15,111 
Many studies have been done on insulin-dependent diabetics and hypoglycemia, 
which have been discussed more in depth in earlier sections. In summary, there is a 
diminished catecholamine response that is primarily due to the decrease in plasma 
epinephrine.
11,57,58,92,113,117,120
 In patients with diabetic neuropathy, the defective 
responses of adrenaline to hypoglycemia were further reduced.
11 
 THE EXERCISE PRESSOR REFLEX IN DIABETIC PATIENTS 
The Roberto study is probably the first, if not the only, study that focuses on the 
hemodynamic response to the muscle metaboreflex in type I diabetics. Roberto and 
colleagues assessed the hemodynamics during the metaboreflex in patients with type I 
diabetes mellitus.
113
 There were 14 type I diabetics and 11 healthy controls in the study. 
The individuals had to perform at a workload that increased linearly on an ergometer 
until exhaustion. The results that were observed were a blunted blood pressure response 
in the patients with diabetes compared to the controls, a reduced capacity to increase 
systemic vascular resistance in the diabetic subjects, and higher stroke volumes as a 
consequence of reduced cardiac afterload in the diabetic subjects compared to the control 
subjects.
113
 Ultimately, the cardiovascular regulation was altered, and there was a reduced 
capacity to increase sympathetic tone in the patients with type I diabetes. The findings of 
a blunted mean arterial blood pressure are indicative of some form of autonomic failure, 
even if autonomic neuropathy is not evident.
9,11,120
 As seen in previous studies, the 
catecholamine levels were reported as being lower than the control group.
113
 Repeated 
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episodes of subclinical hypoglycemia have been thought to be an explanation for 
this.
43,89,113
 This is because at an early age, this reduction in sympathetic activity appears 
to be well tolerated in type I diabetics and the exercise capacity of these individuals was 
normal.
43
 Yet, this condition could decline gradually and lead to symptomatic indicators 
of sympathetic deficit.
113 
Along with the blunted mean blood pressure response, the ability for the patients 
with type I diabetes to increase the systemic vascular resistance, i.e. create arteriolar 
vasoconstriction, was impaired. This observation further supports the indication of there 
being an autonomic deficit in these subjects. However, the researchers found that these 
patients compensated for the deficit by increasing their stroke volume with respect to the 
controls. This occurrence led to a more evident cardiac output response in the group with 
diabetes compared to the controls during the metabolic reflex. In the researchers’ opinion, 
a reduced cardiac afterload was the consequence of the observed stroke volume in these 
patients, which probably caused a more proficient cardiac emptying.
113 
The heart rate between groups was very similar, which speaks against the reduced 
sympathetic tone phenomenon in the diabetic patients. The reduction in the baroreflex 
stimulation could be an explanation for this occurrence, since the mean blood pressure 
was blunted compared to the control group. Because the baroreflex acts as a buffer 
increasing parasympathetic tone at the sinus node during the induced increase of 
sympathetic tone during the metaboreflex, it is possible that there was a reduction in both 
parasympathetic and sympathetic tone that took place in the diabetic patients.
113
 At the 
sinus node, the metaboreflex activation led to a similar sympatho-vagal balance in both 
groups, so the heart rate power spectrum between the groups was not different. 
The data presented in the Roberto study support the idea that the metaboreflex-
induced increase in blood pressure is the consequence of both systemic vascular 
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resistance and cardiac output increments.
113
 There are studies that found conflicting 
results
7,99
; however, other studies support the findings in the Roberto study that the 
metaboreflex-induced increase in blood pressure relies on a flow-mediated mechanism.
101
 
An animal study done on dogs found that the mechanisms responsible for the muscle 
metaboreflex response continuously depend on whether a rise in cardiac output occurs. In 
other words, a rise in cardiac output determines whether vasoconstriction occurs.
63
 
According to the authors of this study, their findings appear to be in line with the concept 
that the rise in blood pressure during the metaboreflex was because there was an increase 
in cardiac output.
113
  
DISCUSSION 
Again, the Roberto study was not performed on individuals with diabetic 
neuropathy; however, the study confirms that in a diabetic individual that is insulin-
dependent, the exercise pressor reflex will be blunted. I believe that only at high 
intensities (i.e. at maximal and submaximal exercises) the exercise pressor reflex will 
truly be affected and not work as efficiently. This is because the exercise pressor reflex is 
made up of two parts: the metaboreflex and the mechanoreflex. It is also highly 
dependent on sympathetic activation. Diabetic neuropathy only affects the sympathetic 
and parasympathetic branches of the nervous system, thus indicating that the production 
of metabolites is affected i.e. the metaboreflex. According to Hilsted, the increase of 
catecholamines, cortisol and growth hormones are depressed during exercise.
56
 If there is 
a depression of the hormones that help makeup sympathetic activation, then in regards to 
the blood vessels, there will be a deficit of sympathetic tone. If sympathetic tone is 
decreased, the mean arterial pressure will be reduced. Having already been observed in 
the Roberto study, the blunted mean blood pressure resulted in a decrease in the 
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baroreflex, which could possibly be explained by a reduction in both sympathetic and 
parasympathetic tone in diabetic patients.
113
 Ultimately, this will lead to a diminished 
exercise pressor reflex. 
To my knowledge, not many studies have been done on the production of the 
algesic substances during exercise that stimulate the nociceptors in patients with diabetes, 
specifically with diabetic neuropathy. Because the parasympathetic and sympathetic 
stimulation is deficient in these individuals, I am making the assumption that the 
nocioceptors of the Group III and IV afferents will be affected and their activation will be 
decreased. This is because in order for the metaboreflex to continue firing, there needs to 
be an accumulation of metabolic products in the contracting muscle,
97
 which I believe 
will not occur as quickly because the parasympathetic and sympathetic stimulation are 
reduced. The mechanoreflex, which responds to skeletal muscle contractions, can still 
function only until muscle glycogen stores are depleted, as discussed in the Kremser 
article. This goes along with the Hilsted findings that the exercise performance and the 
maximal tolerable workload in a patient with diabetic neuropathy will be severely 
impaired.
55
 Overall, I believe that the ergoreceptors of the group III and IV afferents will 
be unaffected because their stimulation is skeletal muscle contraction. They will only be 
affected when the working skeletal muscle is unable to contract due to a shortage of 
oxygen supply and energy availability at higher intensity levels. 
At low to moderate intensities of exercise it is still possible for a patient with 
moderately well-controlled diabetes to use free fatty acids and ketones as a source of 
energy
8
 despite these circulating levels being lower in diabetics compared to normal 
individuals.
120
 Therefore, I believe that the mechanoreflex still would be able to work, not 
maximally, but efficiently. The production of free fatty acids could enhance liver 
gluconeogenesis,
46
 thus releasing more glucose into the plasma and providing more 
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energy for the contracting muscle. Secondly, because the metabolism is not being overly 
stressed and the oxygen demands of the working muscle are compatible with the 
metabolism, the metaboreflex should work efficiently as well.
97
 I believe that the 
ergoreceptors and nocioreceptors will still be activated at low to moderate intensities only 
until the plasma catecholamine levels begin decreasing as the duration of exercise 
continues.  
Schneider et al. investigated the metabolic and hormonal response to exercise in 
individuals with type I diabetes. The subjects were exercised at 60% to 65% of their VO2 
max for 60 minutes. The findings of the study were similar to the numerous studies that 
measured the levels of catecholamines in the blood. The increments of epinephrine and 
norepinephrine were lower in individuals with diabetes compared to those without. 
Hypoglycemia was found during and after exercise in the group with type I diabetes. The 
authors of this study do not believe that the hypoglycemia and subnormal catecholamine 
response is due to autonomic neuropathy but instead due to hyperinsulinemia. They 
found that only after 30 minutes of exercise were there significant differences found in 
the levels of norepinephrine and epinephrine.
120
  
As I stated, I believe the researchers came to this conclusion because the 
individuals were working at moderate intensity. The previously discussed studies that 
concluded that hypoglycemia was due to autonomic neuropathy used exercise tests that 
pushed the participants to exhaustion thereby working at high VO2 levels. I believe that 
had the researchers of this study used comparable methods seen in the other studies, their 
findings would have been different if not similar. 
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